Xarelto is a blood-thinner manufactured by Johnson & Johnson and its subsidiaries Janssen Pharmaceuticals and Bayer Corp. Three common uses for Xarelto include:
- Reducing the risk of stroke in patients with nonvalvular atrial fibrillation;
- Treating deep vein thrombosis and pulmonary embolism; and
- Preventing blood clots in patients following knee or hip replacement surgery.
Like most blood-thinners, Xarelto carries a risk of abnormal bleeding, with bleeding events commonly occurring in the gastrointestinal region and brain. Xarelto, however, carries a significantly higher risk of these bleeding events, which can lead to serious injury and even death. Other adverse reactions to Xarelto include serious swelling and inflammation of the liver known as hepatitis, and other hepatocellular injuries.
On December 12, 2014, the U.S. Judicial Panel on Multi-District Litigation (MDL) filed an order which consolidated all federal Xarelto lawsuits before Judge Eldon Kallon in the Eastern District of Louisiana. Judge Kallon was selected as the judge for these cases based on his experience in handling lawsuits filed against Merck & Co. over its medication Vioxx, which settled for $4.85 billion. More recently, a $650 million settlement was reached over the blood-thinner Pradaxa, which was linked to more than 500 deaths. As more and more victims emerge, Xarelto may prove to be even more deadly than Pradaxa.
Do I have a Case?
Our firm has taken on a number of Xarelto cases involving serious injury or death. Our attorneys provide free and confidential consultations to anyone who has been injured or lost a loved one as a result of Xarelto use. Feel free to Contact Us with any questions or concerns regarding Xarelto.
No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.